# Cardiology Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ernest Shackleton (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX001-SYN-TD
- Date: 1921-05-12
- Fictional facility: St. Posthumous Health Center
- Fictional author: Cormac Ellingsworth-Daly, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- To: Ingrid Solberg-Adebayo, MD, Cardiology
- Urgency: Within two weeks, with coronary CT angiography before or on the day of the visit

## Referral question

Exertional chest tightness and breathlessness for about three months in a 47-year-old heavy smoker who leads a ship-based polar expedition sailing in about four months. Please confirm or exclude obstructive coronary disease, advise on medical therapy and revascularization, and advise whether and how he can safely lead a remote, strenuous, high-latitude expedition. **S**

## Questions for the consultant

1. Does he have obstructive coronary disease, and what is the best first test?
2. Is the heart murmur heard in the past, or a structural problem, part of the picture?
3. How should his medical therapy be optimized?
4. Does he need revascularization, and what would it offer him?
5. Is he fit to lead a remote polar expedition in four months, and what precautions are needed?

## Pertinent history

Chest tightness with breathlessness for about three months on the stairs, carrying loads, and walking fast in cold wind, relieved within minutes by rest; never at rest; no fainting or palpitations. Typical angina by its features. Risk factors: about 25 cigarettes a day since 16 (about 39 pack-years); hazardous drinking (AUDIT 12); LDL cholesterol 168 mg/dL with HDL 38 and triglycerides 200 mg/dL; HbA1c 5.9%; blood pressure 138/86; BMI 28.1. Creatinine 0.98 mg/dL (eGFR 96), potassium 4.4 mmol/L, ALT 41 U/L, hemoglobin 15.8 g/dL, TSH 1.9 mIU/L. Resting ECG: sinus rhythm, no Q waves or ST changes. Breathlessness and weakness on hard exertion during earlier expeditions are part of his history, as is a heart murmur heard by an expedition doctor. Examination today: no murmur, no carotid bruits, lungs clear, no edema. Started today: aspirin 81 mg, atorvastatin 80 mg, metoprolol succinate 50 mg, and sublingual nitroglycerin; varenicline with a quit date in one week; brief alcohol intervention. He is uneasy about examinations and worried that a diagnosis will stop the expedition; he agreed to the referral after his concerns were discussed, and asks that nothing be shared with the expedition's backers without his consent. **S**

- Ernest Henry Shackleton was born on February 15, 1874, at Kilkea, County Kildare, Ireland, the son of Dr. Henry Shackleton, of a well-known Quaker family. **D**
- On the southern sledge journey of the Discovery expedition he became unable to pull the sledge because of breathlessness and weakness; the collapse was attributed to scurvy and "a sort of asthma," and he was invalided home against his will in 1903. **D**
- On the Nimrod expedition (1907 to 1909), its medical officer Eric Marshall recorded in his diary on January 20, 1908, that Shackleton was very unwell after pulling on a rope, and twice heard a pulmonary systolic murmur. **D**
- On the Imperial Trans-Antarctic (Endurance) expedition of 1914 to 1917, of fifty-six men three died in the Antarctic: Mackintosh, Hayward, and Spencer-Smith of the Ross Sea party. No member of the Endurance's own party died. **D**
- His colleague Dr. James McIlroy later recalled that on one occasion Shackleton would not undress and let him listen to his heart. **D**
- He was a heavy cigarette smoker for most of his life. **D**
- After the war he returned to London. In 1921, with John Quiller Rowett taking on practically the whole financial responsibility, he turned his planned Arctic expedition into the Shackleton-Rowett expedition to the South; it was organized and equipped within three months, its sailing was postponed beyond August 20 by a strike of ships' joiners and other delays, and the Quest left St. Katharine's Dock in London on September 17, 1921. **D**

5 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: Total cholesterol: 246 mg/dL (high); HDL cholesterol: 38 mg/dL (low); LDL cholesterol: 168 mg/dL (high); Triglycerides: 200 mg/dL (high); HbA1c: 5.9% (high); Potassium: 4.4 mmol/L; Creatinine: 0.98 mg/dL; ALT: 41 U/L; Hemoglobin: 15.8 g/dL; TSH: 1.9 mIU/L; eGFR: 96 mL/min/1.73 m²; PHQ-2: 1; AUDIT: 12. All results are synthetic.

BP 138/86 mmHg; pulse 78 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 86 kg; BMI 28.1 kg/m². All vital signs are synthetic.

## Current medications

- Aspirin 81 mg delayed-release tablet, one tablet by mouth daily **S**
- Atorvastatin 80 mg tablet, one tablet by mouth daily **S**
- Metoprolol succinate extended-release 50 mg tablet, one tablet by mouth daily **S**
- Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue for chest pain, repeat every 5 minutes up to 3 doses **S**
- Varenicline 1 mg tablet, one tablet by mouth twice a day after a one-week starter titration **S**

## Plan so far

- Medical therapy from intake for suspected angina: aspirin 81 mg, atorvastatin 80 mg, metoprolol succinate, and sublingual nitroglycerin with written instructions to call emergency services if pain lasts more than 5 minutes after the first dose. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026) **S**
- Stop smoking: varenicline for 12 weeks, with the option of 12 more, a quit date in one week, counseling at each visit, and the quitline. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021) **S**
- AUDIT with a brief intervention for hazardous drinking: no more than two drinks a day and several alcohol-free days a week, with AUDIT-C at follow-up. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018) **S**
- Prediabetes: diet and activity counseling and HbA1c in about four months. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); Prediabetes and Type 2 Diabetes: Screening (2021) **S**
